Pennsylvania will receive $90,000 of the $39 million that Daiichi Sankyo must pay in damages and penalties to 49 U.S. states, Washington, DC, and the federal government. The National Association of Medicaid Fraud Control and the federal government recently reached the settlement with Daiichi Sankyo after the New Jersey–based pharmaceutical giant was found to have violated federal law in promoting their drugs Azor, Welchol, Tribenzor, and Benicar.
A ...
continue reading...